Protagonist Therapeutics, Inc. (PTGX)
154.70
+0.38
(+0.25%)
USD |
NASDAQ |
Aug 24, 16:00
154.70
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Price : 154.70 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 152.10 | 154.95 | 150.82 | 154.32 | 402543.0 |
| Aug 20, 2026 | 152.45 | 155.25 | 148.28 | 150.69 | 518560.0 |
| Aug 19, 2026 | 160.81 | 160.81 | 154.22 | 154.94 | 786053.0 |
| Aug 18, 2026 | 157.96 | 160.00 | 156.81 | 157.34 | 471648.0 |
| Aug 17, 2026 | 155.11 | 158.95 | 153.60 | 158.62 | 506961.0 |
| Aug 14, 2026 | 150.23 | 155.53 | 149.17 | 155.10 | 426260.0 |
| Aug 13, 2026 | 153.15 | 154.99 | 150.92 | 151.42 | 444786.0 |
| Aug 12, 2026 | 148.21 | 152.70 | 147.33 | 152.01 | 417204.0 |
| Aug 11, 2026 | 151.88 | 151.88 | 147.37 | 148.29 | 306573.0 |
| Aug 10, 2026 | 149.31 | 151.60 | 147.40 | 150.00 | 545974.0 |
| Aug 07, 2026 | 146.18 | 147.32 | 144.44 | 145.87 | 321085.0 |
| Aug 06, 2026 | 145.01 | 148.00 | 139.95 | 146.18 | 837631.0 |
| Aug 05, 2026 | 137.49 | 138.08 | 135.39 | 137.32 | 430529.0 |
| Aug 04, 2026 | 133.02 | 138.05 | 132.26 | 135.81 | 634672.0 |
| Aug 03, 2026 | 135.78 | 135.98 | 131.68 | 132.28 | 451166.0 |
| Jul 31, 2026 | 138.36 | 138.37 | 131.69 | 136.64 | 548764.0 |
| Jul 30, 2026 | 131.77 | 138.95 | 130.63 | 138.64 | 556393.0 |
| Jul 29, 2026 | 136.90 | 137.43 | 132.72 | 133.00 | 560654.0 |
| Jul 28, 2026 | 136.69 | 137.00 | 133.20 | 136.84 | 282383.0 |
| Jul 27, 2026 | 136.11 | 139.92 | 135.42 | 135.56 | 416781.0 |
| Jul 24, 2026 | 136.11 | 137.20 | 133.78 | 136.11 | 298402.0 |
| Jul 23, 2026 | 133.79 | 137.32 | 132.00 | 135.43 | 605784.0 |
| Jul 22, 2026 | 139.45 | 139.45 | 134.42 | 135.44 | 710439.0 |
| Jul 21, 2026 | 133.34 | 139.72 | 131.05 | 138.31 | 580567.0 |
| Jul 20, 2026 | 141.79 | 143.29 | 133.64 | 134.27 | 762739.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 146.76 |
| Insmed, Inc. | 124.03 |
| Madrigal Pharmaceuticals, Inc. | 511.84 |
| AbbVie, Inc. | 264.49 |
| PTC Therapeutics, Inc. | 71.02 |
Price Related Metrics
| PE Ratio | 149.18 |
| PS Ratio | 36.93 |
| PEG Ratio | 3.276 |
| Price to Book Value | 11.89 |
| Price to Free Cash Flow | 79.76 |
| Earnings Yield | 0.67% |
| Market Cap | 10.00B |
| PEGY Ratio | 3.276 |
| Operating PE Ratio | 178.52 |
| Normalized PE Ratio | 149.17 |